Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAn HTML error page is now shown, indicating the content is temporarily unavailable. This replaces the previously visible study record details and attachments with an error screen.SummaryDifference20%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe site revision updated from v3.6.3 to v3.6.4, signaling a minor software update behind the pages with no visible changes to study details.SummaryDifference0.0%

- Check52 days agoChange DetectedThe revision label updated from v3.6.2 to v3.6.3. This indicates a minor deployment update and does not change the study details on the page.SummaryDifference0.0%

- Check59 days agoChange Detected- The page's revision indicator was updated from v3.6.0 to v3.6.2, reflecting a new build. This signals a small site update without altering the study content or primary features.SummaryDifference0.0%

- Check73 days agoChange DetectedThe study page now explicitly states that recruitment has ended ('No longer looking for participants'). It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users in understanding the study record and participation steps.SummaryDifference0.5%

- Check80 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating an internal update to the document version. No visible changes to study details or interface are indicated by this revision.SummaryDifference0.0%

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.